Ngā hua rapu - Tim Endy
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
Intracellular Cytokine Production by Dengue Virus–specific T cells Correlates with Subclinical Secondary Infection mā Steven C. Hatch, Tim Endy, Stephen J. Thomas, Anuja Mathew, James Potts, Pamela Pazoles, Daniel H. Libraty, Robert V. Gibbons, Alan L. Rothman
I whakaputaina 2011Artigo -
2
Characterising the benefits and risks of vaccines approved through accelerated pathways mā Bethan Cracknell Daniels, Tim Endy, Joseph A. Lewnard, José Luis Di Fábio, Oscar Cortes-Azuero, Gabrielle Breugelmans, Simon Cauchemez, Alexander Roberto Precioso, Albert I. Ko, Rebecca E. Chandler, Stephen J. Thomas, Nicole Lurie, Henrik Salje
I whakaputaina 2025Pré-impressão -
3
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines mā Kirsten Vannice, Annelies Wilder‐Smith, Alan D.T. Barrett, Kalinka Carrijo, Marco Cavaleri, Aravinda de Silva, Anna P. Durbin, Tim Endy, Eva Harris, Bruce L. Innis, Leah C. Katzelnick, Peter G. Smith, Wellington Sun, Stephen J. Thomas, Joachim Hombach
I whakaputaina 2018Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Dengue fever
Dengue virus
Immunology
Medicine
Biochemistry
Biology
Business
Clinical trial
Cytokine
Dengue vaccine
Environmental health
Immune system
In vitro
Intensive care medicine
Licensure
Nursing
Pathology
Peripheral blood mononuclear cell
Population
Public health
Risk analysis (engineering)
Subclinical infection
Vaccination
Vaccine efficacy
Virology
Virus
Whole blood